Cathy Skala

As a CEO and Board Director, I bring board value through strategic governance, operational oversight, and human capital alignment to enhance shareholder value across the medical device, pharma, and health tech sectors. I have updated large public healthcare companies such as Abbott (NYSE: ABT), Hospira (NYSE: HSP) - currently Pfizer (NYSE: PFE), and Baxter (NYSE: BAX), through restructurings, mergers, divestitures, and cultural transformations, improving operating margins by 900 basis points over four years.
Through my work in multiple functions and with various countries, I have refined my authenticity and curiosity capabilities. I champion a transparent, direct, and empathetic culture that promotes organizational resilience and delivers a competitive advantage. I help dedicated leaders look around corners, stress-test existing strategies, and determine necessary pivots. I help prepare organizations for the future.